Precigen Inc logo

PGEN

Precigen Inc

$2.22

Earnings Summary

Revenue
$32.02Mn
Net Profits
$-19.25Mn
Net Profit Margins
-60.12%

Highlights

Revenue:

Precigen Inc’s revenue jumped 30.64% since last year same period to $32.02Mn in the Q1 2022. On a quarterly growth basis, Precigen Inc has generated 32.2% jump in its revenue since last 3-months.

Net Profits:

Precigen Inc’s net profit fell -11.16% since last year same period to $-19.25Mn in the Q1 2022. On a quarterly growth basis, Precigen Inc has generated 23.1% jump in its net profits since last 3-months.

Net Profit Margins:

Precigen Inc’s net profit margin jumped 14.91% since last year same period to -60.12% in the Q1 2022. On a quarterly growth basis, Precigen Inc has generated 41.83% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Precigen Inc post its latest quarter earnings

EPS Estimate Current Quarter
-0.13
EPS Estimate Current Year
-0.13

Highlights

EPS Estimate Current Quarter:

Precigen Inc’s earning per share (EPS) estimates for the current quarter stand at -0.13 - a 0% jump from last quarter’s estimates.

EPS Estimate Current Year:

Precigen Inc’s earning per share (EPS) estimates for the current year stand at -0.13.

Key Ratios

Key ratios of the Precigen Inc post its Q1 2022 earnings

Earning Per Share (EPS)
-0.1
Return on Assets (ROA)
-0.13
Return on Equity (ROE)
-0.83
Dividend Per Share (DPS)
0

Highlights

Earning Per Share (EPS):

Precigen Inc’s earning per share (EPS) fell -11.11% since last year same period to -0.1 in the Q1 2022. This indicates that the Precigen Inc has generated -11.11% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Precigen Inc’s return on assets (ROA) stands at -0.13.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Precigen Inc’s return on equity (ROE) stands at -0.83.

Dividend Per Share (DPS):

Precigen Inc declared 0 dividend per share during the earnings announcement for Q1 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-05-09
-0.13
-0.1
23.08%

Company Information

Precigen is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target the most urgent and intractable diseases in its core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. The Company's technologies enable to find innovative solutions for affordable biotherapeutics in a controlled manner. Precigen operates as an innovation engine progressing a preclinical and clinical pipeline of well-differentiated unique therapies toward clinical proof-of-concept and commercialization.

Organisation
Precigen Inc
Headquarters
20374 Seneca Meadows Parkway, Germantown, MD, United States, 20876
Employees
194
Industry
Health Technology
CEO
Helen Sabzevari